- CA$90.94m
- -CA$2.22m
- $191.26m
- 53
- 75
- 30
- 53
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 54.7 | 84.3 | 47.3 | 111 | 191 |
Cost of Revenue | |||||
Gross Profit | 54 | 86.5 | 45.8 | 113 | 191 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -6.49 | 130 | 146 | 96.9 | 322 |
Operating Profit | 61.2 | -46.1 | -98.4 | 14 | -131 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 46 | -55.8 | -107 | 13.9 | -131 |
Provision for Income Taxes | |||||
Net Income After Taxes | 43.8 | -59.2 | -109 | 10.3 | -138 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 43.8 | -59.2 | -109 | 10.3 | -138 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 43.8 | -59.2 | -109 | 10.3 | -138 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.018 | -0.009 | -0.093 | 0.039 | 0.009 |